Higgons John Duncan Insider Trades

Insider Trading History

Track insider trading activity for Higgons John Duncan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Jounce Therapeutics
Jounce Therapeutics JNCE
Director
Holding Value $37.6k 20,000 shares
Last Trade
Jun 24, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56k 20,000 shares
$2.80
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Director
Holding Value $29.5k 15,700 shares
Last Trade
Jun 18, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$114k 15,700 shares
$7.27
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Director
Holding Value $18.3k 9,713 shares
Last Trade
Apr 15, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$2k 200 shares
$10.00
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Director
Holding Value $18.6k 9,913 shares
Last Trade
Mar 15, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.56k 200 shares
$12.80
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Director
Holding Value $19k 10,113 shares
Last Trade
Feb 16, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.36k 200 shares
$11.78
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Director
Holding Value $19.4k 10,313 shares
Last Trade
Jan 21, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.22k 200 shares
$11.11
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Director
Holding Value $19.8k 10,513 shares
Last Trade
Jan 20, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$18k 1,500 shares
$12.00
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Director
Holding Value $25.5k 13,550 shares
Last Trade
Jun 26, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$103k 13,550 shares
$7.58
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Director
Holding Value $29.5k 15,700 shares
Last Trade
Jun 26, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$119k 15,700 shares
$7.58
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Director
Holding Value $22.6k 12,013 shares
Last Trade
Jan 06, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$12.2k 1,500 shares
$8.11
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Director
Holding Value $29.5k 15,700 shares
Last Trade
Jun 12, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$70k 15,700 shares
$4.46
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Director
Holding Value $25.5k 13,550 shares
Last Trade
Jun 19, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$107k 13,550 shares
$7.92
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Director
Holding Value $50.8k 27,025 shares
Last Trade
Feb 01, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$107k 6,700 shares
$16.00
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Director
Holding Value $38.2k 20,325 shares
Last Trade
Jan 26, 2017 Sale
No data
No data
$1.88
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Operating Officer
Holding Value $3.48M 120,834 shares
Last Trade
Jan 04, 2016 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.75M 58,999 shares
$63.64
$28.79
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Operating Officer
Holding Value $5.24M 182,088 shares
Last Trade
Jan 04, 2016 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.75M 58,999 shares
$63.64
$28.79
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Operating Officer
Holding Value $1.78M 61,835 shares
Last Trade
Dec 15, 2015 Sale (Open Market)Shares sold on the open market or in a private sale.
$1M 20,000 shares
$50.09
$28.79
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Operating Officer
Holding Value $6.88M 239,112 shares
Last Trade
Dec 03, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.04M 34,090 shares
$59.87
$28.79
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Operating Officer
Holding Value $2.93M 101,835 shares
Last Trade
Nov 16, 2015 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.18M 20,000 shares
$59.13
$28.79
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Operating Officer
Holding Value $6.16M 214,113 shares
Last Trade
Nov 16, 2015 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.18M 20,000 shares
$59.13
$28.79

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up